PillATC B06AA03
Hyaluronidase
8 US drug concepts across dosage forms & routes
8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
All forms8 active · 0 discontinued
Every dosage form and route registered under this substance. Each links to its own price trend, supplier list, and regulatory history.
| Drug | Form | Route | Type | Status |
|---|---|---|---|---|
| Hyaluronidase | Injection, Solution | Subcutaneous | rx | 2 SUPPLYING |
| Amivantamab And Hyaluronidase-Lpuj (Human Recombinant) | Injection | Subcutaneous | rx | 1 SUPPLYING |
| Daratumumab And Hyaluronidase-Fihj (Human Recombinant) | Injection | Subcutaneous | rx | 1 SUPPLYING |
| Efgartigimod Alfa And Hyaluronidase (Human Recombinant) | Injection, Solution | Subcutaneous | rx | 1 SUPPLYING |
| Hyaluronidase | Injection | Subcutaneous | rx | 1 SUPPLYING |
| Immune Globulin Infusion (Human), 10% With Recombinant Human Hyaluronidase | Kit | — | other | 1 SUPPLYING |
| Nivolumab And Hyaluronidase-Nvhy | Injection, Solution | Subcutaneous | rx | 1 SUPPLYING |
| Ocrelizumab And Hyaluronidase | Injection, Solution | Subcutaneous | rx | 1 SUPPLYING |
Grouped by WHO ATC classification (via RxNorm) — one substance across every US dosage form and route on file. See the methodology for how the ATC mapping and supplier counts are built.